CNBC
Novo Nordisk shares slide after guidance disappoints investors
Novo Nordisk raised its financial outlook as it tries to catch up with rival Eli Lilly in the booming GLP-1 market.
Brief by WorldPing · Original reporting by CNBC
WorldPingBitmine said it now holds about 4.8% of Ether’s circulating supply as it pursues its 5% acquisition target.
This is a short WorldPing brief. The full report was published by Cointelegraph.
Read the full report at CointelegraphNovo Nordisk raised its financial outlook as it tries to catch up with rival Eli Lilly in the booming GLP-1 market.
Brief by WorldPing · Original reporting by CNBC